NCT00002981View on ClinicalTrials.gov

PET Scan in Treating Patients With Metastatic Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

January 31, 1997

Primary Completion Date

June 12, 2023

Study Completion Date

June 12, 2023

Conditions
Prostate Cancer
Interventions
PROCEDURE

positron emission tomography

RADIATION

fludeoxyglucose F 18

RADIATION

methionine C 11

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002981 - PET Scan in Treating Patients With Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter